HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cordialin

RN given refers to compound with unknown MF

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - cordialin: 3
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - cordialin: 3
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - cordialin: 3

Related Diseases

1.	Ischemia 08/01/1990 - "Based on experimental studies the possibility of cordialin use in acute ischemia is being substantiated. " 07/01/1991 - "The results received may be a theoretical basis for cordialin utilization in therapy of myocardial diseases, associated with hypoxia and ischemia. " 03/01/1992 - "Cordialin correction of the biologic energy of cardiomyocytes in hypoxia and ischemia prevents the accumulation of lipid drops in the cells of the peri-infarction zone, which reflects the high intensity of the processes of fatty acids beta-oxidation. "
2.	Myocardial Infarction 08/01/1990 - "Cordialin use in early stages of myocardial infarction is suggested. " 07/01/1991 - "Cordialin utilization may be recommended for the treatment of acute myocardial infarction and for prolongation of time-period for thrombolytic therapy, treatment of IMD, angina and other pathological states, in which oxygen transport disturbance to myocardium cells occurs."
3.	Hypoxia (Hypoxemia) 07/01/1991 - "The results received may be a theoretical basis for cordialin utilization in therapy of myocardial diseases, associated with hypoxia and ischemia. " 07/01/1991 - "Cordialin, the agent extracted from the heart, is known to inhibit hyperoxidation of succinic acid, increasing NADH oxidation speed in suspension of cardiomyocytes in hypoxia. " 03/01/1992 - "Cordialin correction of the biologic energy of cardiomyocytes in hypoxia and ischemia prevents the accumulation of lipid drops in the cells of the peri-infarction zone, which reflects the high intensity of the processes of fatty acids beta-oxidation. "
4.	Cardiomyopathies (Cardiomyopathy) 07/01/1991 - "The results received may be a theoretical basis for cordialin utilization in therapy of myocardial diseases, associated with hypoxia and ischemia. "
5.	Infarction (Infarctions) 03/01/1992 - "Cordialin correction of the biologic energy of cardiomyocytes in hypoxia and ischemia prevents the accumulation of lipid drops in the cells of the peri-infarction zone, which reflects the high intensity of the processes of fatty acids beta-oxidation. "

Related Drugs and Biologics

1.	Succinic Acid (Succinate)
2.	Suspensions
3.	Oxygen (Dioxygen)
4.	NAD (NADH)
5.	Lipids
6.	Fatty Acids (Saturated Fatty Acids)

Related Therapies and Procedures

1.	Thrombolytic Therapy
2.	Therapeutics